<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03682354</url>
  </required_header>
  <id_info>
    <org_study_id>M2018123</org_study_id>
    <nct_id>NCT03682354</nct_id>
  </id_info>
  <brief_title>ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery</brief_title>
  <official_title>Erector Spinae Plane Block Versus Intercostal Nerve Block Combined With Patient-controlled Intravenous Analgesia in Video-assisted Thoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized prospective trial to test the non-inferiority of erector spinae plane block
      (ESPB) in comparison with intercostal nerve block combined with patient-controlled
      intravenous analgesia in Thoracoscopic lung surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For patients undergoing thoracic surgery, postoperative pain greatly limited their
      recovery.Multimodal analgesia have shown good efficacy but without reaching full pain relief.

      The primary goal of this study is to observe the effect of ultrasound-guided erector spinae
      plane block in comparison with intercostal nerve block combined with patient-controlled
      intravenous analgesia in video assisted thoracic lung surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 27, 2018</start_date>
  <completion_date type="Actual">March 15, 2019</completion_date>
  <primary_completion_date type="Actual">March 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score (NRS)</measure>
    <time_frame>4 hours from the end of procedure</time_frame>
    <description>Numeric Rating Scale is an 11-point scale used by doctors to evaluate patients' pain, where 0 is no pain and 10 the worst imaginable pain. For postoperative patients, an higher score shows inadequate analgesia and worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score (NRS)</measure>
    <time_frame>8, 24,48 hours from the end of procedure</time_frame>
    <description>Numeric Rating Scale is an 11-point scale used by doctors to evaluate patients' pain, where 0 is no pain and 10 the worst imaginable pain. For postoperative patients, an higher score shows inadequate analgesia and worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesics consumption</measure>
    <time_frame>During operation,4, 8, 24,48 hours from the end of procedure</time_frame>
    <description>Analgesics include opioids and nonsteroidal anti-inflammatory drugs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of side effects and complication during study</measure>
    <time_frame>During operation,4, 8, 24,48 hours from the end of procedure</time_frame>
    <description>Side effects and complication</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Lung Diseases</condition>
  <arm_group>
    <arm_group_label>Intercostal Nerve Block with PCIA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intercostal Nerve Block with patient-controlled intravenous analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erector Spinae Plane Block (ESPB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous Erector Spinae Plane Block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intercostal Nerve Block with PCIA</intervention_name>
    <description>Intercostal nerve block consists in the injection of Ropivacaine (4 ml,0.5%) in related intercostal spaces. Patient-controlled intravenous analgesia regimen is conducted with sufentanil.</description>
    <arm_group_label>Intercostal Nerve Block with PCIA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Erector Spinae Plane Block (ESPB)</intervention_name>
    <description>Erector Spinae Plane Block consists in the injection of Ropivacaine (20ml, 0.5%), in the anatomical plane between the Erector Spinae muscles and transverse process, laterally to the spinous process of T5 . The catheter was inserted and secured in place under ecographic guidance, and a patient-controlled regional anesthesia regimen was conducted with 0.2% ropivacaine.</description>
    <arm_group_label>Erector Spinae Plane Block (ESPB)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients to receive video assisted thoracoscopic lobectomy or bullectomy .

        Exclusion Criteria:

          -  1. Patient refusal 2. Heavy skin eruption and infection at site of injection. 3.
             Coagulopathy. 4. Allergy to local anesthetics. 5. Taking analgesics.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min Li</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>August 26, 2018</study_first_submitted>
  <study_first_submitted_qc>September 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2018</study_first_posted>
  <last_update_submitted>March 26, 2019</last_update_submitted>
  <last_update_submitted_qc>March 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Erector spinae plane block</keyword>
  <keyword>Video-assisted thoracic surgery;</keyword>
  <keyword>Intercostal nerve block</keyword>
  <keyword>Patient-controlled intravenous analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

